TheStreptococcuspneumoniaeCapsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms
Top Cited Papers
Open Access
- 1 February 2010
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 78 (2) , 704-715
- https://doi.org/10.1128/iai.00881-09
Abstract
The Streptococcuspneumoniae capsule is vital for virulence and may inhibit complement activity and phagocytosis. However, there are only limited data on the mechanisms by which the capsule affects complement and the consequences for S. pneumoniae interactions with phagocytes. Using unencapsulated serotype 2 and 4 S. pneumoniae mutants, we have confirmed that the capsule has several effects on complement activity. The capsule impaired bacterial opsonization with C3b/iC3b by both the alternative and classical complement pathways and also inhibited conversion of C3b bound to the bacterial surface to iC3b. There was increased binding of the classical pathway mediators immunoglobulin G (IgG) and C-reactive protein (CRP) to unencapsulated S. pneumoniae, indicating that the capsule could inhibit classical pathway complement activity by masking antibody recognition of subcapsular antigens, as well as by inhibiting CRP binding. Cleavage of serum IgG by the enzyme IdeS reduced C3b/iC3b deposition on all of the strains, but there were still marked increases in C3b/iC3b deposition on unencapsulated TIGR4 and D39 strains compared to encapsulated strains, suggesting that the capsule inhibits both IgG-mediated and IgG-independent complement activity against S. pneumoniae. Unencapsulated strains were more susceptible to neutrophil phagocytosis after incubation in normal serum, normal serum treated with IdeS, complement-deficient serum, and complement-deficient serum treated with IdeS or in buffer alone, suggesting that the capsule inhibits phagocytosis mediated by Fcγ receptors, complement receptors, and nonopsonic receptors. Overall, these data show that the S. pneumoniae capsule affects multiple aspects of complement- and neutrophil-mediated immunity, resulting in a profound inhibition of opsonophagocytosis.Keywords
This publication has 68 references indexed in Scilit:
- Acquisition of factor H by a novel surface protein on group BStreptococcuspromotes complement degradationThe FASEB Journal, 2009
- Impaired Opsonization with C3b and Phagocytosis ofStreptococcus pneumoniaein Sera from Subjects with Defects in the Classical Complement PathwayInfection and Immunity, 2008
- Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulenceMolecular Microbiology, 2007
- Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal diseaseClinical and Experimental Immunology, 2007
- Live Attenuated Streptococcus pneumoniae Strains Induce Serotype-Independent Mucosal and Systemic Protection in MiceInfection and Immunity, 2007
- Pneumolysin, PspA, and PspC Contribute to Pneumococcal Evasion of Early Innate Immune Responses during Bacteremia in MiceInfection and Immunity, 2007
- Capsule Enhances Pneumococcal Colonization by Limiting Mucus-Mediated ClearanceInfection and Immunity, 2007
- The Macrophage Scavenger Receptor SR-AI/II and Lung Defense against Pneumococci and ParticlesAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Development and Validation of a Fourfold Multiplexed Opsonization Assay (MOPA4) for Pneumococcal AntibodiesClinical and Vaccine Immunology, 2006
- Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive diseaseProceedings of the National Academy of Sciences, 2006